Bristol-Myers Squibb Company (NYSE: BMY)
Overview
Bristol-Myers Squibb (BMS) may be a giant in transition, but its still a pharmaceutical giant. The company's blockbuster cardiovascular lineup includes heart disease drug Plavix and Avapro for hypertension. BMS also makes antipsychotic medication Abilify and HIV treatments Reyataz and Sustiva. Most of the company's sales come from products in the therapeutic areas of cardiovascular, immunoscience, metabolics, neuroscience, oncology, and virology. BMS, which has 12 manufacturing plants worldwide and conducts research and development in four countries, sells its products globally; the US accounts for two thirds of sales.
Sample Overview & HistoryKey Numbers from Hoover's UK
Key financials for Bristol-Myers Squibb Company (NYSE: BMY)
| Company Type | Public (NYSE: BMY) |
|---|---|
| Fiscal Year-End | December |
| 2011 Sales (mil.) | £13,432.6 |
| 1-Year Sales Growth | 9.0% |
| 2011 Net Income (mil.) | £2,345.2 |
| 1-Year Net Income Growth | 19.6% |
| 2010 Employees | 27,000 |
| 1-Year Employee Growth | (3.6%) |
Key People from Hoover's UK
Key people and executives for Bristol-Myers Squibb Company (NYSE: BMY)
| Chairman | James M. (Jim) Cornelius (Subscribers see complete biographies -- view sample)
|
|---|---|
| CEO and Director | Lamberto Andreotti |
| SVP Global Development and Medical Affairs, Research and Development | Brian Daniels |
Top Competitors from Hoover's UK
Top competitors of Bristol-Myers Squibb Company (NYSE: BMY)
There are 20 competitors for Bristol-Myers Squibb; see more.Significant Developments
View company events at Bristol-Myers Squibb Company (NYSE: BMY) such as IPOs, bankruptcies, or executive changes
| Event | Details |
|---|---|
| Top Executive Change | Subscribers get full details -- view a sample |
| Top Executive Change |
Industry Information from Hoover's UK
First Research Industry Profiles Extensive Industry Intelligence
Hoover's Industries
- Pharmaceuticals(primary)
Subsidiaries/Affiliates Covered By Hoover's UK
Subsidiaries/affiliates of Bristol-Myers Squibb Company (NYSE: BMY)
Rankings from Hoover's UK
See how Bristol-Myers Squibb Company (NYSE: BMY) ranks in standard industry listings such as Fortune 500, S&P 500, and Dow Jones
- #131 in FORTUNE 500 (May 2011)
- S&P 500
- #131 in FORTUNE 1000 (May 2011)
- #177 in FT Global 500 (June 2011)

